Literature DB >> 11907150

Pharmacology and toxicology of astrocyte-neuron glutamate transport and cycling.

Ursula Sonnewald1, Hong Qu, Michael Aschner.   

Abstract

The interaction between astrocytes and neurons is examined from the standpoint of glutamate neurotoxicity. The review details 1. the distribution of glutamate transporters on astrocytes and neurons, provoking a reformulation of the interdependence between these two cell types in removing extracellular glutamate and preventing excitotoxic injury; 2. the potential involvement of aberrant glutamate transporter function in the etiology of neuropathological conditions; 3. the role of astrocyte-neuron interaction in widely divergent aspects of brain energetics; 4. the role of astrocytes in the process of glutamate recycling within the context of anesthetic treatment with pentobarbital and thiopental.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907150     DOI: 10.1124/jpet.301.1.1

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Comparative analysis of changes in membrane currents in neurons and astrocytes in rat hippocampal slices after stimulation of glutamatergic transmission.

Authors:  M Yu Iniouchine; D A Sibarov; A B Vol'nova
Journal:  Dokl Biol Sci       Date:  2013-05-08

2.  Induction of S100B secretion in C6 astroglial cells by the major metabolites accumulating in glutaric acidemia type I.

Authors:  André Quincozes-Santos; Rafael Borba Rosa; Guilhian Leipnitz; Daniela Fraga de Souza; Bianca Seminotti; Moacir Wajner; Carlos Alberto Gonçalves
Journal:  Metab Brain Dis       Date:  2010-05-01       Impact factor: 3.584

Review 3.  Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.

Authors:  Keetae Kim; Seok-Geun Lee; Timothy P Kegelman; Zhao-Zhong Su; Swadesh K Das; Rupesh Dash; Santanu Dasgupta; Paola M Barral; Michael Hedvat; Paul Diaz; John C Reed; John L Stebbins; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  J Cell Physiol       Date:  2011-10       Impact factor: 6.384

4.  Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.

Authors:  Amy E Steffek; Robert E McCullumsmith; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2008-06-17       Impact factor: 4.939

5.  Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult.

Authors:  Andrew D Kraft; Delinda A Johnson; Jeffrey A Johnson
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

6.  A sequential impairment of cortical astrocytes and GABAergic neurons during ischemia is improved by mGluR₁,₅ activation.

Authors:  Zhan Liu; Wei Huo; Wei Sun; Manhua Lv; Fang Li; Zhiqiang Su
Journal:  Neurol Sci       Date:  2012-10-31       Impact factor: 3.307

7.  Lactate rescues neuronal sodium homeostasis during impaired energy metabolism.

Authors:  Claudia Karus; Daniel Ziemens; Christine R Rose
Journal:  Channels (Austin)       Date:  2015-06-03       Impact factor: 2.581

8.  Acidosis-Induced Dysfunction of Cortical GABAergic Neurons through Astrocyte-Related Excitotoxicity.

Authors:  Li Huang; Shidi Zhao; Wei Lu; Sudong Guan; Yan Zhu; Jin-Hui Wang
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

9.  Baicalin combats glutamate excitotoxicity via protecting glutamine synthetase from ROS-induced 20S proteasomal degradation.

Authors:  Xianrui Song; Zixuan Gong; Kaili Liu; Junping Kou; Baolin Liu; Kang Liu
Journal:  Redox Biol       Date:  2020-05-16       Impact factor: 11.799

10.  Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application.

Authors:  Chen Benkler; Daniel Offen; Eldad Melamed; Lana Kupershmidt; Tamar Amit; Silvia Mandel; Moussa B H Youdim; Orly Weinreb
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.